The Use of an Antifibrosis Agent to Improve Muscle Recovery after Laceration *

Muscle injuries are challenging problems in traumatology and the most frequent injuries in sports medicine. Muscle injuries are capable of healing, although slowly and occasionally with incomplete functional recovery. We observed that lacerated muscle undergoes a rapid process of regeneration, which is hindered by the development of fibrosis. Biologic approaches to enhance muscle regeneration and prevent fibrosis are being investigated to improve muscle healing after injuries. We observed that growth factors can improve muscle regeneration but cannot prevent muscle fibrosis. We investigated the use of an antifibrosis substance, decorin, as an approach to prevent fibrosis and thereby improve muscle healing after injury in murine muscle. We observed that direct injection of human recombinant decorin can efficiently prevent fibrosis and enhance muscle regeneration in the lacerated muscle. More importantly, decorin can improve the recovery of strength in the injured muscle to a level similar to that observed in normal noninjured muscle. These results suggest that injection of decorin improves both the muscle structure and the function of the lacerated muscle to near complete recovery. This study will contribute significantly to the development of strategies to promote efficient muscle healing and complete functional recovery after muscle injuries.

[1]  Freddie H. Fu,et al.  Suturing Versus Immobilization of a Muscle Laceration , 1999, The American journal of sports medicine.

[2]  A. Musarò,et al.  Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Freddie H. Fu,et al.  Development of approaches to improve the healing following muscle contusion. , 1998, Cell transplantation.

[4]  Johnny Huard,et al.  Development of Approaches to Improve Cell Survival in Myoblast Transfer Therapy , 1998, The Journal of cell biology.

[5]  Freddie H. Fu,et al.  Biologic Intervention in Muscle Healing and Regeneration , 1998 .

[6]  R. Braun,et al.  Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. , 1997, Biochemical pharmacology.

[7]  S. Lamberts,et al.  The endocrinology of aging. , 1997, Science.

[8]  R. Chamuleau,et al.  Transforming growth factor-β-induced collagen synthesis by human liver myofibroblasts is inhibited by α2-macroglobulin , 1997 .

[9]  K. Moriyama,et al.  Transforming growth factor-beta 1 modulates myofibroblastic phenotype of rat palatal fibroblasts in vitro. , 1997, Experimental cell research.

[10]  J R Florini,et al.  Growth hormone and the insulin-like growth factor system in myogenesis. , 1996, Endocrine reviews.

[11]  R. Coutts,et al.  Instructional Course Lectures, The American Academy of Orthopaedic Surgeons - Growth Factors as Therapeutic Agents*† , 1996 .

[12]  L. S. Quinn,et al.  Overexpression of the type‐1 insulin‐like growth factor receptor increases ligand‐dependent proliferation and differentiation in bovine skeletal myogenic cultures , 1996, Journal of cellular physiology.

[13]  J. C. McDermott,et al.  Molecular basis of skeletal muscle regeneration. , 1996, Canadian journal of applied physiology = Revue canadienne de physiologie appliquee.

[14]  M. Schambelan,et al.  Growth Hormone Replacement in Healthy Older Men Improves Body Composition but Not Functional Ability , 1996, Annals of Internal Medicine.

[15]  Y. Kaneda,et al.  Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney , 1996, Nature Medicine.

[16]  S. Teichberg,et al.  Effect of insulin-like growth factor I in murine muscular dystrophy. , 1995, Endocrinology.

[17]  L. Morandi,et al.  Expression of transforming growth factor-beta 1 in dystrophic patient muscles correlates with fibrosis. Pathogenetic role of a fibrogenic cytokine. , 1995, The Journal of clinical investigation.

[18]  S. Johnson,et al.  Activation of skeletal muscle satellite cells and the role of fibroblast growth factor receptors. , 1995, Experimental cell research.

[19]  T. Best,et al.  Incomplete, Intrasubstance Strain Injuries of the Rectus Femoris Muscle , 1995, The American journal of sports medicine.

[20]  Robert J. Schwartz,et al.  Myogenic Vector Expression of Insulin-like Growth Factor I Stimulates Muscle Cell Differentiation and Myofiber Hypertrophy in Transgenic Mice (*) , 1995, The Journal of Biological Chemistry.

[21]  J. Lefaucheur,et al.  Muscle regeneration following injury can be modified in vivo by immune neutralization of basic fibroblast growth factor, transforming growth factor β1 or insulin-like growth factor I , 1995, Journal of Neuroimmunology.

[22]  M. Panjabi,et al.  A Muscle Contusion Injury Model , 1994, The American journal of sports medicine.

[23]  H. Blau,et al.  Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy , 1994, The Journal of cell biology.

[24]  A. Seaber,et al.  Experimental muscle strain injury , 1993, The American journal of sports medicine.

[25]  L. Brocks,et al.  Vimentin and desmin expression in degenerating and regenerating dystrophic murine muscles , 1992, Virchows Archiv. B, Cell pathology including molecular pathology.

[26]  J. Aronen,et al.  Quadriceps Contusions. , 1992, The Physician and sportsmedicine.

[27]  S. Furner,et al.  Musculoskeletal Conditions in the United States , 1992 .

[28]  H. Kalimo,et al.  Activation of myogenic precursor cells after muscle injury. , 1992, Medicine and science in sports and exercise.

[29]  H. Schmalbruch,et al.  Desmin and vimentin in regenerating muscles , 1992, Muscle & nerve.

[30]  E. Kardami,et al.  Distinctive patterns of basic fibroblast growth factor (bFGF) distribution in degenerating and regenerating areas of dystrophic (mdx) striated muscles. , 1991, Developmental biology.

[31]  M. Järvinen,et al.  Healing of skeletal muscle injury: an ultrastructural and immunohistochemical study. , 1991, Medicine and science in sports and exercise.

[32]  K. Dreher,et al.  Vascular smooth muscle biglycan represents a highly conserved proteoglycan within the arterial wall. , 1990, European journal of cell biology.

[33]  W. Garrett Muscle strain injuries: clinical and basic aspects. , 1990, Medicine and science in sports and exercise.

[34]  E. Jennische Sequential immunohistochemical expression of IGF-I and the transferrin receptor in regenerating rat muscle in vivo. , 1989, Acta endocrinologica.

[35]  E. Schultz,et al.  Satellite cell behavior during skeletal muscle growth and regeneration. , 1989, Medicine and science in sports and exercise.

[36]  M. Fardeau,et al.  Regeneration of skeletal muscle fibers from autologous satellite cells multiplied in vitro. An experimental model for testing cultured cell myogenicity , 1989, Muscle & nerve.

[37]  J. Florini,et al.  Effects of growth factors on myogenic differentiation. , 1989, The American journal of physiology.

[38]  I. Siegel,et al.  Injury and Repair of the Musculoskeletal Soft Tissues , 1988 .

[39]  J. Morley,et al.  Endocrinology in aging. , 1988, Disease-a-month : DM.

[40]  H. Hansson,et al.  Regenerating skeletal muscle cells express insulin-like growth factor I. , 1987, Acta physiologica Scandinavica.

[41]  A. Seaber,et al.  Biomechanical and histological evaluation of muscle after controlled strain injury , 1987, The American journal of sports medicine.

[42]  Henry E. Robson,et al.  Sports injuries—their prevention and treatment , 1986 .

[43]  E. Schultz,et al.  Response of satellite cells to focal skeletal muscle injury , 1985, Muscle & nerve.

[44]  W E Garrett,et al.  Recovery of skeletal muscle after laceration and repair. , 1984, The Journal of hand surgery.

[45]  Jacques Menetrey,et al.  Growth factors improve muscle healing in vivo , 2000 .

[46]  H. Freddie,et al.  SUTURING VERSUS IMMOBILIZATION OF A MUSCLE LACERATION: A MORPHOLOGICAL AND FUNCTIONAL STUDY , 1999 .

[47]  W M Petroll,et al.  Neutralizing antibody to TGFbeta modulates stromal fibrosis but not regression of photoablative effect following PRK. , 1998, Current eye research.

[48]  R. Chamuleau,et al.  Transforming growth factor-beta-induced collagen synthesis by human liver myofibroblasts is inhibited by alpha2-macroglobulin. , 1997, Journal of Hepatology.

[49]  R. Coutts,et al.  Growth factors as therapeutic agents. , 1997, Instructional course lectures.

[50]  M. Grounds Towards understanding skeletal muscle regeneration. , 1991, Pathology, research and practice.

[51]  J. Faulkner,et al.  The regeneration of skeletal muscle fibers following injury: a review. , 1983, Medicine and science in sports and exercise.

[52]  V. Krejci,et al.  Muscle and tendon injuries in athletes : diagnosis, treatment, muscle training, rehabilitation , 1979 .

[53]  J A Feagin,et al.  Quadriceps contusions in young athletes. Relation of severity of injury to treatment and prognosis. , 1973, The Journal of bone and joint surgery. American volume.